Modulation of neurotrophic signaling pathways by polyphenols F Moosavi, R Hosseini, L Saso, O Firuzi Drug design, development and therapy, 23-42, 2015 | 280 | 2015 |
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers F Moosavi, E Giovannetti, L Saso, O Firuzi Critical reviews in clinical laboratory sciences 56 (8), 533-566, 2019 | 132 | 2019 |
Plant glutathione S-transferase classification, structure and evolution S Mohsenzadeh, M Esmaeili, F Moosavi, M Shahrtash, B Saffari, ... African Journal of Biotechnology 10 (42), 8160-8165, 2011 | 77 | 2011 |
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer M Mortazavi, F Moosavi, M Martini, E Giovannetti, O Firuzi Critical reviews in oncology/hematology 176, 103749, 2022 | 48 | 2022 |
Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review Z Haghighijoo, L Zamani, F Moosavi, S Emami European Journal of Medicinal Chemistry 227, 113949, 2022 | 33 | 2022 |
Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer F Moosavi, E Giovannetti, GJ Peters, O Firuzi Critical Reviews in Oncology/hematology 160, 103234, 2021 | 29 | 2021 |
Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents F Moosavi, R Hosseini, H Rajaian, T Silva, DM e Silva, L Saso, N Edraki, ... Bioorganic & Medicinal Chemistry 25 (12), 3235-3246, 2017 | 26 | 2017 |
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met T Damghani, F Moosavi, M Khoshneviszadeh, M Mortazavi, S Pirhadi, ... Scientific Reports 11 (1), 3644, 2021 | 25 | 2021 |
Caffeic acid alkyl amide derivatives ameliorate oxidative stress and modulate ERK1/2 and AKT signaling pathways in a rat model of diabetic retinopathy M Fathalipour, M Eghtedari, F Borges, T Silva, F Moosavi, O Firuzi, ... Chemistry & Biodiversity 16 (12), e1900405, 2019 | 19 | 2019 |
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3, 4-dihydropyrimidin-2 (1H)-one C5 amide derivatives F Moosavi, A Ebadi, M Mohabbati, T Damghani, M Mortazavi, R Miri, ... European Journal of Pharmacology 894, 173850, 2021 | 16 | 2021 |
Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold R Hosseini, F Moosavi, H Rajaian, T Silva, D Magalhaes e Silva, ... Chemical Biology & Drug Design 88 (6), 926-937, 2016 | 11 | 2016 |
Modulation of ERK1/2 and Akt pathways involved in the neurotrophic action of caffeic acid alkyl esters R Hosseini, F Moosavi, T Silva, H Rajaian, SY Hosseini, S Bina, L Saso, ... Molecules 23 (12), 3340, 2018 | 6 | 2018 |
Analysis of synonymous codon usage bias and nucleotide and amino acid composition in 13 species of Flaviviridae F Moosavi, H Mohabatkar, S Mohsenzadeh JOURNAL OF CELL AND MOLECULAR RESEARCH 3 (1), 1-11, 2011 | 5 | 2011 |
Computer-aided analysis of structural properties and epitopes of Iranian HPV-16 E7 oncoprotein F Moosavi, H Mohabatkar, S Mohsenzadeh Interdisciplinary Sciences: Computational Life Sciences 2, 367-372, 2010 | 5 | 2010 |
Plant glutathione S-transferase function M Esmaeili, M Shahrtash, F Moosavi, S Mohsenzadeh, H Mohabatkar The 6th National Biotechnol. Congress of Iran, 2009 | 5 | 2009 |
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors M Mortazavi, M Divar, T Damghani, F Moosavi, L Saso, S Pirhadi, ... Frontiers in Chemistry 10, 969559, 2022 | 4 | 2022 |
In silico screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agents F Moosavi, T Damghani, S Ghazi, S Pirhadi Journal of Receptors and Signal Transduction, 1-13, 2022 | 4 | 2022 |
Computer-Assisted analysis of subcellular localization signals and post-translational modifications of human prion proteins F Moosawi, H Mohabatkar Journal of Biomedical Science and Engineering 2 (01), 70, 2009 | 4 | 2009 |
Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients A Abbaspour, M Dehghani, M Setayesh, M Tavakkoli, HA Rostamipour, ... Cancer Chemotherapy and Pharmacology 92 (6), 475-483, 2023 | 2 | 2023 |
Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: an in silico … A Poustforoosh, F Moosavi Journal of Biomolecular Structure and Dynamics, 1-13, 2023 | 2 | 2023 |